Our previous research confirmed that mesentery functions can be improved by regulating the level of adipokines (Metrnl) in CD, including reducing mesenteric hypertrophy, improving adipocyte intrinsic function and ameliorating MAT inflammation, further relieving CD‐like colitis.9 Here, METRNL is linked to Cowden disease.